Comparative Study of Coadministered Ceftaroline Fosamil and NXL104 vs. Intravenous Doripenem in Adult Subjects With Complicated Urinary Tract Infections

NCT01281462 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

217

Enrollment

INDUSTRY

Sponsor class

Conditions

Urinary Tract Infections

Interventions

DRUG: Ceftaroline fosamil and NXL104 (q8h)
DRUG: Ceftaroline fosamil and NXL104 (q12h)
DRUG: Doripenem
DRUG: Placebo

Sponsor

Forest Laboratories